Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(OP:
SDZXF
)
49.00
UNCHANGED
Streaming Delayed Price
Updated: 3:44 PM EDT, May 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
49.00
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
49.00
Today's Range
49.00 - 49.00
52wk Range
34.11 - 49.83
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug
April 14, 2025
Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the inflammatory disease market.
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
February 24, 2025
Multiple sclerosis patients report severe side effects, including relapses and mobility issues, after switching from Tysabri to Tyruko in an NHS cost-saving move. Regulators and experts are assessing...
Via
Benzinga
Performance
YTD
+19.7%
+19.7%
1 Month
+10.1%
+10.1%
3 Month
+6.0%
+6.0%
6 Month
+8.0%
+8.0%
1 Year
+43.7%
+43.7%
More News
Read More
Why Is Coherus BioSciences Stock Trading Higher On Tuesday?
December 03, 2024
Via
Benzinga
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
September 11, 2024
Via
Benzinga
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
April 30, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Generic/Biosimilar Player Sandoz Settles US Price Fixing Case For $265M
February 29, 2024
Via
Benzinga
Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?
January 22, 2024
Via
Benzinga
Venue Turmoil: Pharma Companies Oppose States' Bid to Relocate Price-Fixing Cases
December 04, 2023
Via
Benzinga
Frequently Asked Questions
Is SDZXF publicly traded?
Yes, SDZXF is publicly traded.
What exchange does SDZXF trade on?
SDZXF trades on the OTC Traded
What is the ticker symbol for SDZXF?
The ticker symbol for SDZXF is SDZXF on the OTC Traded
What is the current price of SDZXF?
The current price of SDZXF is 49.00
When was SDZXF last traded?
The last trade of SDZXF was at 05/21/25 03:44 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.